Therefore, as CSF1 and FGF signals are both involved in the accumulation of tumor- promoting M2 macrophages, MDSCs, and Tregs (44), the dual inhibition of CSF1R and FGFR1 by sulfatinib may be more effective for cancer therapy than selective CSF1R inhibition. Here, FGFR1 is linked to cancer.